Baird lowered the firm’s price target on Dentsply Sirona to $31 from $33 and keeps a Neutral rating on the shares. With dental stocks underperforming the S&P 500 by 20 points year-to-date, “a lot of bad is clearly priced into the group,” the analyst tells investors in a research note. The firm says that while dental fundamentals remain challenging, investor sentiment “feels even more negative.” It believes “now is the time to tip-toe back into dental.”
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on XRAY:
- Dentsply Sirona price target lowered to $28 from $30 at Stifel
- Ex-Dividend Date Nearing for These 10 Stocks – Week of June 24, 2024
- Dentsply Sirona Provides Update on June Investor Conference Participation
- SPX Technologies appoints Johnson as Chief Legal Officer
- Dentsply Sirona to Participate in Upcoming Investor Conferences